Browsed by
Tag: share

Retirees Share Secrets to Financial Security | Aging

Retirees Share Secrets to Financial Security | Aging

You don’t necessarily need a lot of money to set up a financially secure retirement. If you’re willing to carefully manage your expenses, you may be able to retire with a modest budget.

RELATED CONTENT

Here’s how to retire well on less money:

  • Know what you want.
  • Start saving early.
  • Don’t chase high-risk investments.
  • Save above-average earnings.
  • Reduce housing costs.
  • Line up utility payments.
  • Get rid of car debt.
  • Move to a less expensive area.
  • Stretch small items.

Know What You Want

Thinking about your interests can help you set aside funds to cover retirement activities. If you’re married, “Take the time to agree on what you want retirement to look like,” says Mike Smith, who retired at age 63 and currently lives in Windermere, Florida. That’s what he did prior to leaving the workforce. “We have traveled the world and will be leaving our family well set,” Smith says.

Start Saving Early

Putting aside funds well before retirement can provide the chance to build wealth through compound interest. “When money is saved and invested, then your money makes more money; then that money makes even more money,” says Marco Sison, who retired in 2015 at age 41 after working in business development for Erickson helicopters. “I funded my first retirement account at age 20.”

Don’t Chase High-Risk Investments

While some financial opportunities may look incredibly promising, diversifying savings and taking a slow and steady approach can lead to higher long-term results. “Don’t look at bitcoin, starting a new business or chasing individual stocks,” Sison says. “I keep my retirement savings in a bond and broad market ETF portfolio.” One rule of thumb to diversify involves subtracting your age from 100. The result can then be the percentage of your portfolio that is invested in stocks. For example, if you

Read the rest
Electric cars to triple market share in Europe amid COVID-19, researchers say

Electric cars to triple market share in Europe amid COVID-19, researchers say

By Kate Abnett



text: A battery charger sign for electric cars is painted on the ground of a parking ground near the soccer stadium in Wolfsburg


© Reuters/Kai Pfaffenbach
A battery charger sign for electric cars is painted on the ground of a parking ground near the soccer stadium in Wolfsburg

BRUSSELS (Reuters) – Electric vehicles made up 8% of car sales in Europe in the first half of 2020, putting them on track to triple their market share this year, according to analysis by the NGO Transport & Environment (T&E).

Loading...

Load Error

While the novel coronavirus pandemic has seen overall car sales plummet, sales of electric cars – which T&E defined as both battery and plug-in hybrid models – have increased.

This saw electric cars more than triple their market share in the European Economic Area (EEA), compared with the first half of last year, T&E said.

Outright sales of such vehicles are expected to roughly double this year, to one million units, it said.

T&E attributed the sales increase to tougher European Union car emissions standards, which took effect this year, and post-pandemic purchase incentives in Germany and France.

The NGO expects carmakers to meet the 2020 emissions standards, which would see electric and plug-in hybrid vehicles triple their market share in 2020 to 10% of EEA car sales.

“It is because of the EU emissions standards, but it is also thanks to many investments carmakers made last year,” report co-author Julia Poliscanova said.

The European Automobile Manufacturers’ Association (ACEA) said electric vehicle sales have been boosted by national support schemes to foster economic recovery from the COVID-19 pandemic but that this trend was not necessarily a long-term one.

“It is difficult to make any predictions on future long-term shifts in consumer behaviour from such ‘artificial’ growth driven by subsidies,” ACEA said.

T&E urged the EU to set tougher future emissions targets to ensure electric vehicles keep edging out polluting models.

Read the rest
Caesars Sports Betting Bid On William Hill Could Lead To Market Share Dominance (NASDAQ:CZR)

Caesars Sports Betting Bid On William Hill Could Lead To Market Share Dominance (NASDAQ:CZR)

“Companies that grow for the sake of growth or that expand into areas outside their core business strategy often stumble. On the other hand, companies that build scale for the benefit of their customers and shareholders more often succeed over time” Jamie Dimon CEO JPMorgan Chase

Caesars Entertainment Corp’s (CZR) move last week to acquire William Hill PLC (WMH) is a classic play right out of the Jamie Dimon playbook as noted in the above quote. You can impose any number of standard metrics to the proposed deal that translate to a stock that is forecasted by analysts to run a wild best case worse case gauntlet between $54 and $75 a share going forward. In brief, the questions fairly asked here if you go by familiar data points this this: Is CZR grabbing for seconds before it digests its first main dish? Does a case of indigestion await management? Taking on $17.3b in debt to buy CZR is one thing. Then in fast order, reach for a UK sports betting giant in a deal now valued at $3.7b is quite another.foxbusiness.com markets>williamhill>backs>caesars

Or is it? We’t think this big appetite reach by CZR is all about strategy, not financial engineering.

ChartData by YCharts

It is an example of a clear headed vision that will be transformative. It’s a perfectly logical move made with speed and daring at a time when many observers felt, that El Dorado (ERI) would be too busy digesting and deleveraging CZR to do anything dramatic on its sport betting business but possibly spin it off. This is not a numbers cruncher’s exercise. There are financial aspects of this deal that can be head scratchers. This is all about recognizing and acting swiftly when you know you have a hot hand. CZR has a hot hand.

Read the rest
Telehealth Market 2020 | Global Share, Key Companies, Growth, Industry Analysis, Revenue, Regional Overview, Outlook and Forecasts 2026

Telehealth Market 2020 | Global Share, Key Companies, Growth, Industry Analysis, Revenue, Regional Overview, Outlook and Forecasts 2026

The “Telehealth Market 2020” is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.

Report Highlights:

  • Detailed Historical Overview
  • Consumer and Pricing Analysis
  • Market Dynamics of the Industry
  • In-depth Market Segmentation
  • Historical and Projected Market Sizing in Terms of Value
  • Recent Market Trends and Impact Factors
  • R&D Status and Technology Overview
  • Extensive Industry Structure Coverage

Key Companies and Manufacturers Covered:

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight.

  • American Well
  • Teladoc Health
  • Doctor On Demand
  • GlobalMed
  • Dictum Health, Inc
  • LLC
  • InTouch Technologies, Inc.
  • MDLIVE Inc.
  • Encounter Telehealth
  • HelloMD
  • SnapMD, Inc.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telehealth-market-101065

Technological Advancements to Fuel Demand for Telehealth Services

The technological advancements in telehealth products and services have fuelled the demand for telehealth services across the world. The advent of user-friendly systems has contributed to a high demand, which in turn has led to an increase in the global telehealth market value in recent years. In 2019, InTouch announced the launch of a fully integrated end-to-end virtual platform aimed at providing enhanced patient care solutions. ‘Solo’ was a flexible platform integrated with services such as enhanced emergency care solutions, direct-to-patient, and direct-to-customer, which in turn will contribute to the growth of the global telehealth market in the coming

Read the rest
Would Shareholders Who Purchased Infinity Pharmaceuticals’ (NASDAQ:INFI) Stock Five Years Be Happy With The Share price Today?

Would Shareholders Who Purchased Infinity Pharmaceuticals’ (NASDAQ:INFI) Stock Five Years Be Happy With The Share price Today?

It is a pleasure to report that the Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) is up 42% in the last quarter. But will that repair the damage for the weary investors who have owned this stock as it declined over half a decade? Probably not. Like a ship taking on water, the share price has sunk 87% in that time. The recent bounce might mean the long decline is over, but we are not confident. The real question is whether the business can leave its past behind and improve itself over the years ahead.

We really feel for shareholders in this scenario. It’s a good reminder of the importance of diversification, and it’s worth keeping in mind there’s more to life than money, anyway.

Check out our latest analysis for Infinity Pharmaceuticals

We don’t think Infinity Pharmaceuticals’ revenue of US$1,438,000 is enough to establish significant demand. This state of affairs suggests that venture capitalists won’t provide funds on attractive terms. As a result, we think it’s unlikely shareholders are paying much attention to current revenue, but rather speculating on growth in the years to come. For example, they may be hoping that Infinity Pharmaceuticals comes up with a great new product, before it runs out of money.

We think companies that have neither significant revenues nor profits are pretty high risk. There is almost always a chance they will need to raise more capital, and their progress – and share price – will dictate how dilutive that is to current holders. While some such companies do very well over the long term, others become hyped up by promoters before eventually falling back down to earth, and going bankrupt (or being recapitalized). Infinity Pharmaceuticals has already given some investors a taste of the bitter losses that high risk investing can cause.

Infinity Pharmaceuticals

Read the rest